|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pecorelli S, Zigliani L and Odicino F:
Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol
Obstet. 105:107–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol.
73:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keys HM, Bundy BN, Stehman FB, Muderspach
LI, Chafe WE, Suggs CL III, Walker JL and Gersell D: Cisplatin
radiation and adjuvant hysterectomy compared with radiation and
adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl
J Med. 340:1154–1161. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakamura K, Kitahara Y, Satoh T, Takei Y,
Takano M, Nagao S, Sekiguchi I and Suzuki M: Analysis of the effect
of adjuvant radiotherapy on outcomes and complications after
radical hysterectomy in FIGO stage IB1 cervical cancer patients
with intermediate risk factors (GOTIC Study). World J Surg Oncol.
14:1732016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim H, Park W, Kim YS and Kim YJ:
Chemoradiotherapy is not superior to radiotherapy alone after
radical surgery for cervical cancer patients with intermediate-risk
factor. J Gynecol Oncol. 31:e352020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song S, Song C, Kim HJ, Wu HG, Kim JH,
Park NH, Song YS, Kim JW, Kang SB and Ha SW: 20 year experience of
postoperative radiotherapy in IB-IIA cervical cancer patients with
intermediate risk factors: Impact of treatment period and
concurrent chemotherapy. Gynecol Oncol. 124:63–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ryu SY, Park SI, Nam BH, Cho CK, Kim K,
Kim BJ, Kim MH, Choi SC, Lee ED and Lee KH: Is adjuvant
chemoradiotherapy overtreatment in cervical cancer patients with
intermediate risk factors? Int J Radiat Oncol Biol Phys.
79:794–799. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin YZ, Pei CZ and Wen LY: FLNA is a
predictor of chemoresistance and poor survival in cervical cancer.
Biomark Med. 10:711–719. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Imai K, Fukuda T, Wada T, Kawanishi M,
Tasaka R, Yasui T and Sumi T: UCP2 expression may represent a
predictive marker of neoadjuvant chemotherapy effectiveness for
locally advanced uterine cervical cancer. Oncol Lett. 14:951–957.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stossel TP, Condeelis J, Cooley L, Hartwig
JH, Noegel A, Schleicher M and Shapiro SS: Filamins as integrators
of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2:138–145.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Robertson SP, Twigg SR, Sutherland-Smith
AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E,
Newbury-Ecob R, et al: Localized mutations in the gene encoding the
cytoskeletal protein filamin A cause diverse malformations in
humans. Nat Genet. 33:487–491. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Keshamouni VG, Michailidis G, Grasso CS,
Anthwal S, Strahler JR, Walker A, Arenberg DA, Reddy RC, Akulapalli
S, Thannickal VJ, et al: Differential protein expression profiling
by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing
epithelial-mesenchymal transition reveals a migratory/invasive
phenotype. J Proteome Res. 5:1143–1154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ai J, Huang H, Lv X, Tang Z, Chen M, Chen
T, Duan W, Sun H, Li Q, Tan R, et al: FLNA and PGK1 are two
potential markers for progression in hepatocellular carcinoma. Cell
Physiol Biochem. 27:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin JF, Xu J, Tian HY, Gao X, Chen QX, Gu
Q, Xu GJ, Song JD and Zhao FK: Identification of candidate prostate
cancer biomarkers in prostate needle biopsy specimens using
proteomic analysis. Int J Cancer. 121:2596–2605. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Larriba MJ, Martín-Villar E, Garcia JM,
Pereira F, Peña C, de Herreros AG, Bonilla F and Muñoz A: Snail2
cooperates with snail1 in the repression of vitamin D receptor in
colon cancer. Carcinogenesis. 30:1459–1468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Flanagan LA, Chou J, Falet H, Neujahr R,
Hartwig JH and Stossel TP: Filamin A, the Arp2/3 complex, and the
morphology and function of cortical actin filaments in human
melanoma cells. J Cell Biol. 155:511–517. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Komurov K, Wright WE and Shay JW:
Identification of novel driver tumor suppressors through functional
interrogation of putative passenger mutations in colorectal cancer.
Int J Cancer. 132:732–737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Kim S, Jia G, Buhmeida A, Dallol
A, Wright WE, Fornace AJ, Al-Qahtani M and Shay JW: Exome
sequencing of normal and isogenic transformed human colonic
epithelial cells (HCECs) reveals novel genes potentially involved
in the early stages of colorectal tumorigenesis. BMC Genomics. 16
(Suppl 1):S82015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pecqueur C, Alves-Guerra MC, Gelly C,
Levi-Meyrueis C, Couplan E, Collins S, Ricquier D, Bouillaud F and
Miroux B: Uncoupling protein 2, in vivo distribution, induction
upon oxidative stress, and evidence for translational regulation. J
Biol Chem. 276:8705–8712. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bo J, Xie S, Guo Y, Zhang C, Guan Y, Li C,
Lu J and Meng QH: Methylglyoxal impairs insulin secretion of
pancreatic beta-cells through increased production of ROS and
mitochondrial dysfunction mediated by upregulation of UCP2 and
MAPKs. J Diabetes Res. 2016:20298542016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Horimoto M, Resnick MB, Konkin TA,
Routhier J, Wands JR and Baffy G: Expression of uncoupling
protein-2 in human colon cancer. Clin Cancer Res. 10:6203–6207.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berthiaume E, Derdak Z, Konkin TA, Resnick
MB, Wands JR and Baffy G: Increased expression of uncoupling
protein-2 in cholangiocarcinoma cells may confer resistance to
apoptosis. Hepatology. 40:372A–373A. 2004.
|
|
26
|
Sayeed A, Meng Z, Luciani G, Chen LC,
Bennington JL and Dairkee SH: Negative regulation of UCP2 by TGFβ
signaling characterizes low and intermediate-grade primary breast
cancer. Cell Death Dis. 1:e532010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harper ME, Antoniou A, Villalobos-Menuey
E, Russo A, Trauger R, Vendemelio M, George A, Bartholomew R, Carlo
D, Shaikh A, et al: Characterization of a novel metabolic strategy
used by drug-resistant tumor cells. FASEB J. 16:1550–1557. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bray F, Carstensen B, Møller H, Zappa M,
Zakelj MP, Lawrence G, Hakama M and Weiderpass E: Incidence trends
of adenocarcinoma of the cervix in 13 European countries. Cancer
Epidemiol Biomarkers Prev. 14:2191–2199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bray F, Loos AH, McCarron P, Weiderpass E,
Arbyn M, Møller H, Hakama M and Parkin DM: Trends in cervical
squamous cell carcinoma incidence in 13 European countries:
Changing risk and the effects of screening. Cancer Epidemiol
Biomarkers Prev. 14:677–686. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bray F, Lortet-Tieulent J, Znaor A,
Brotons M, Poljak M and Arbyn M: Patterns and trends in human
papillomavirus-related diseases in Central and Eastern Europe and
Central Asia. Vaccine. 31:H32–H45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bedolla RG, Wang Y, Asuncion A, Chamie K,
Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra
R, et al: Nuclear versus cytoplasmic localization of filamin A in
prostate cancer: Immunohistochemical correlation with metastases.
Clin Cancer Res. 15:788–796. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan
QJ, Zhang X, Chang BF, Zhang SK, Guo HQ and Qiao YL: Evaluation of
p16/Ki-67 dual staining in detection of cervical precancer and
cancers: A multicenter study in China. Oncotarget. 7:21181–21189.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niault TS and Baccarini M: Targets of raf
in tumorigenesis. Carcinogenesis. 31:1165–1174. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wong KK: Recent developments in
anti-cancer agents targeting the Ras/Raf/MEK/ERK pathway. Recent
Pat Anticancer Drug Discov. 4:28–35. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Watanabe H: Extracellular
matrix-regulation of cancer invasion and metastasis. Gan To Kagaku
Ryoho. 37:2058–2061. 2010.(In Chinese). PubMed/NCBI
|
|
38
|
Ogata Y, Matono K, Nakajima M, Sasatomi T,
Mizobe T, Nagase H and Shirouzu K: Efficacy of the MMP inhibitor
MMI270 against lung metastasis following removal of orthotopically
transplanted human colon cancer in rat. Int J Cancer. 118:215–221.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lai WC, Zhou M, Shankavaram U, Peng G and
Wahl LM: Differential regulation of lipopolysaccharide-induced
monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and
extracellular signal-regulated kinase 1/2 mitogen-activated protein
kinases. J Immunol. 170:6244–6249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rauvala M, Aglund K, Puistola U,
Turpeenniemi-Hujanen T, Horvath G, Willén R and Stendahl U: Matrix
metalloproteinases-2 and −9 in cervical cancer: Different roles in
tumor progression. Int J Gynecol Cancer. 16:1297–1302. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu TN, He HJ, Kole S, D'Souza T, Agarwal
R, Morin PJ and Bernier M: Filamin A-mediated down-regulation of
the exchange factor Ras-GRF1 correlates with decreased matrix
metalloproteinase-9 expression in human melanoma cells. J Biol
Chem. 282:14816–14826. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Derdak Z, Mark NM, Beldi G, Robson SC,
Wands JR and Baffy G: The mitochondrial uncoupling protein-2
promotes chemoresistance in cancer cells. Cancer Res. 68:2813–2819.
2008. View Article : Google Scholar : PubMed/NCBI
|
